Drug intelligence / Profile preview

betaxolol

Development stage
Approved
Lead developer
Alcon
Modality
Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Betaxolol is a cardioselective beta-blocker (beta-1 adrenergic antagonist) used primarily to treat hypertension and open-angle glaucoma. It works by selectively blocking beta-1 adrenergic receptors in the heart, leading to decreased heart rate, cardiac output, and blood pressure. When administered ophthalmically, it reduces intraocular pressure by decreasing aqueous humor production in the eye. Unlike non-selective beta-blockers, betaxolol has minimal effect on beta-2 receptors and thus a lower risk of bronchospasm. It does not exhibit intrinsic sympathomimetic or significant membrane-stabilizing activity. Approved uses include essential hypertension (oral), open-angle glaucoma and ocular hypertension (ophthalmic), with additional use in chronic stable angina and post-myocardial infarction.

Brand names
KerloneBetopticBetoptic SBetoptic Pilo
Other names
BétaxololBetaxololum
02

Targets

ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on betaxolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betaxolol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call